Efficacy Clinical studies have shown that Semaglutide can lead to substantial weight loss, with patients experiencing an average of 15% weight reduction over 68 weeks
Lis A, Kawakiewicz W, Kubisz L
Tirzepatide is a biologic drug, a 39-amino-acid peptide with a fatty acid modification that gives it its extended half-life
Some therapies like PRP injections, physical rehabilitation, and nutritional support may be complementary and enhance results, while others might require timing adjustments or modifications to avoid interference
These sensations may be related to nausea, changes in oral sensations, or gastrointestinal reflux associated with delayed gastric emptying
For this reason, manufacturers recommend discontinuing semaglutide at least two months before attempting pregnancy